Ahmed Elkashef

3.4k citations

58 papers · 2.4k indexed · h-index 28

Cellular and Molecular Neuroscience top 1%
Pharmacology top 1%
Psychiatry and Mental health top 2%
Molecular Biology
Epidemiology top 10%

Co-authors: Frank J. Vocci Roberta Kahn Richard Jed Wyatt Nora Chiang Jane B. Acri D. Blöch John D. Roache A. Anderson
Topics: Neurotransmitter Receptor Influence on Behavior (39 papers)Substance Abuse Treatment and Outcomes (13 papers)Cannabis and Cannabinoid Research (12 papers)
Cited by: Toxicology Cellular and Molecular Neuroscience Biological Psychiatry
Journals: American Journal of Psychiatry Clinical Infectious Diseases Biological Psychiatry
Partner nations: United States Australia South Korea

In The Last Decade

Ahmed Elkashef

58 papers receiving 2.4k citations

Peers

Countries citing papers authored by Ahmed Elkashef

Since Specialization

Citations

This map shows the geographic impact of Ahmed Elkashef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed Elkashef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed Elkashef more than expected).

Fields of papers citing papers by Ahmed Elkashef

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmed Elkashef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed Elkashef. The network helps show where Ahmed Elkashef may publish in the future.

Co-authorship network of co-authors of Ahmed Elkashef

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmed Elkashef. A scholar is included among the top collaborators of Ahmed Elkashef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmed Elkashef. Ahmed Elkashef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bupropion for the treatment of methamphetamine dependence in non-daily users: A randomized, double-blind, placebo-controlled trial 2015 ·Drug and Alcohol Dependence ·A. Anderson,(unknown),Denka Markova,Tyson H. Holmes,Nora Chiang,Roberta Kahn,Jan Campbell,Daniel L. Dickerson,Gantt P. Galloway,William Haning,John D. Roache,Christopher Stock,Ahmed Elkashef	49
2	Safety of Atomoxetine in Combination With Intravenous Cocaine in Cocaine-Experienced Participants 2012 ·Journal of Addiction Medicine ·Louis R. Cantilena,Roberta Kahn,Connie C. Duncan,Shou-Hua Li,A. Anderson,Ahmed Elkashef	14
3	Modafinil for the treatment of methamphetamine dependence 2011 ·Drug and Alcohol Dependence ·A. Anderson,Shou-Hua Li,Kousick Biswas,Frances McSherry,Tyson H. Holmes,Erin Iturriaga,Roberta Kahn,Nora Chiang,Thomas P. Beresford,Jan Campbell,William Haning,Joseph Mawhinney,Michael McCann,Richard A. Rawson,Christopher Stock,(unknown),Elmer Yu,Ahmed Elkashef	82
4	Interventions for HIV and Hepatitis C Virus Infections in Recreational Drug Users 2010 ·Clinical Infectious Diseases ·Jag Khalsa,Ahmed Elkashef	11
5	Modafinil for the treatment of cocaine dependence 2009 ·Drug and Alcohol Dependence ·A. Anderson,Malcolm S. Reid,(unknown),Tyson H. Holmes,Lynn Shemanski,April Slee,Edwina Smith,Roberta Kahn,Nora Chiang,Frank J. Vocci,Domenic A. Ciraulo,Charles A. Dackis,John D. Roache,Ihsan M. Salloum,Eugene Somoza,Harold C. Urschel,Ahmed Elkashef	175
6	Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals 2009 ·Drug and Alcohol Dependence ·Roberta Kahn,Kousick Biswas,(unknown),Steven Shoptaw,Paul J. Fudala,(unknown),Iván D. Montoya,Joseph Collins,Frances McSherry,Shou-Hua Li,Nora Chiang,(unknown),(unknown),Joseph Liberto,Thomas P. Beresford,Christopher Stock,Christopher L. Wallace,Valerie A. Gruber,Ahmed Elkashef	56
7	Drug Interactions between Antiretroviral Medications and Medications Used in the Treatment of Drug Addiction: Research Needs 2009 ·American Journal on Addictions ·Jag Khalsa,Ahmed Elkashef	9
8	A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal☆ 2008 ·Drug and Alcohol Dependence ·Elmer Yu,Karen Miotto,Evaristo Akerele,Ann Elizabeth Montgomery,Ahmed Elkashef,(unknown),Iván D. Montoya,Marian W. Fischman,Joseph Collins,Frances McSherry	47
9	Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers 2008 ·The International Journal of Neuropsychopharmacology ·Thomas F. Newton,Malcolm S. Reid,Richard De La Garza,James J. Mahoney,Antonio Abad,Rany Condos,Joseph J. Palamar,Perry N. Halkitis,(unknown),A. Anderson,(unknown),Ahmed Elkashef	47
10	Biotechnology and the Treatment of Addictive Disorders 2007 ·BioDrugs ·Ahmed Elkashef,(unknown),Jane B. Acri,Frank J. Vocci	11
11	The SRPHK1 outcome measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study day 2007 ·Drug and Alcohol Dependence ·Eugene Somoza,(unknown),Daniel Lewis,Shou-Hua Li,Theresa Winhusen,Nora Chiang,Frank J. Vocci,Paul S. Horn,Ahmed Elkashef	11
12	A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence 2007 ·The International Journal of Neuropsychopharmacology ·Bankole A. Johnson,Nassima Ait‐Daoud,Ahmed Elkashef,Edwina Smith,Roberta Kahn,(unknown),Shou-Hua Li,D. Blöch,(unknown)	104
13	The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity 2007 ·Addiction ·Ahmed Elkashef,Richard A. Rawson,Edwina Smith,(unknown),Frank Flammino,Jan Campbell,(unknown),Charles W. Gorodetzky,William Haning,Joseph Mawhinney,Michael McCann,(unknown),(unknown),Walter Ling,Frank J. Vocci	11
14	Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence 2006 ·Drug and Alcohol Dependence ·Ahmed Elkashef,Paul J. Fudala,(unknown),Shou-Hua Li,Roberta Kahn,Nora Chiang,Frank J. Vocci,Joseph Collins,Karen Jones,Kathy D. Boardman,Mike R. Sather	40
15	Safety of intravenous methamphetamine administration during treatment with bupropion 2005 ·Psychopharmacology ·Thomas F. Newton,John D. Roache,Richard De La Garza,(unknown),Christopher L. Wallace,(unknown),Ahmed Elkashef,Nora Chiang,Roberta Kahn	49
16	Modafinil Influences the Pharmacokinetics of Intravenous Cocaine in Healthy Cocaine-Dependent Volunteers 2005 ·Clinical Pharmacokinetics ·Jennifer L. Donovan,C. Lindsay DeVane,Robert Malcolm,(unknown),C. Nora Chiang,Ahmed Elkashef,Robin M. Taylor	20
17	Cocaine Rapid Efficacy Screening Trials (CREST): lessons learned 2005 ·Addiction ·Kyle M. Kampman,Deborah B. Leiderman,Tyson H. Holmes,Joseph S. LoCastro,D. Blöch,Malcolm S. Reid,Steven Shoptaw,Margaret A. Montgomery,Theresa Winhusen,Eugene Somoza,Domenic A. Ciraulo,Ahmed Elkashef,Frank J. Vocci	18
18	Medication Development for Addictive Disorders: The State of the Science 2005 ·American Journal of Psychiatry ·Frank J. Vocci,Jane B. Acri,Ahmed Elkashef	137
19	Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence 2005 ·Addiction ·Ahmed Elkashef,Tyson H. Holmes,D. Blöch,Steven Shoptaw,Kyle M. Kampman,Malcolm S. Reid,Eugene Somoza,Domenic A. Ciraulo,John Rotrosen,Deborah B. Leiderman,Ann Elizabeth Montgomery,Frank J. Vocci	29
20	A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence 2005 ·Addiction ·Sandy Berger,Theresa Winhusen,Eugene Somoza,Judy M. Harrer,Juris P. Mezinskis,Deborah B. Leiderman,Margaret A. Montgomery,R. Jeffrey Goldsmith,D. Blöch,Bonita Singal,Ahmed Elkashef	53

About Ahmed Elkashef

Ahmed Elkashef is a scholar working on Toxicology, Cellular and Molecular Neuroscience and Pharmacology, having authored 58 papers that have together received 2.4k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (39 papers), Substance Abuse Treatment and Outcomes (13 papers) and Cannabis and Cannabinoid Research (12 papers). The work is most often cited by research in Toxicology (273 citations), Cellular and Molecular Neuroscience (1.4k citations) and Biological Psychiatry (126 citations). Ahmed Elkashef has collaborated with scholars based in United States, Australia and South Korea. Frequent co-authors include Frank J. Vocci, Roberta Kahn, Richard Jed Wyatt, Nora Chiang, Jane B. Acri, D. Blöch, John D. Roache, A. Anderson, Shou-Hua Li and Tyson H. Holmes. Their work appears in journals such as American Journal of Psychiatry, Clinical Infectious Diseases and Biological Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact